PELLICANO, CLELIA

PELLICANO, CLELIA  

DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO  

Mostra prodotti
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial 2018 Antonini, A1; 2, ; Gentile, G2; Giglio, M2; Marcante, A1; 2, ; Gage, H3; Touray, Mml4; Fotiadis, Di5; Gatsios, D5; Konitsiotis, S6; Timotijevic, L7; Egan, B7; Hodgkins, C7; Biundo, R2; Pellicano, C; Hatzakis, H; Correia Jesuino, Jorge; Antonini, A; Marcante, A; Biundo, R; Gentile, G; Manuela, G; Weis, L; Chiarot, M; Zanin, V; Seljak, Bk; Cestnik, B; Aleksovski, D; Miljkovic, D; Novak, F; Bohanec, M; Anzic, T; Podpecan, V; Valmarska, A; Papa, G; Blazica, B; Boshkoska, Bm; Vilzmann, R; Assogna, F; Spalletta, G; Pellicano, C; Pellicano, Gr; Palma, V; Scudellari, C; Soru, T; Napoletano, ANTONELLO MARIO; Fanciulli, F; Raffaelli, M; Banks, THOMAS ALLEN; Elliot, B; Hodgkins, C; Seiss, E; Gage, H; Timotijevic, L; Egan, B; Rusconi, P; Peacock, M; Gillies, S; Puttock, E; Touray, Mml; Gatsios, D; Gatsios, D; Rigas, G; Fotiadis, D; VON FALKENHAUSEN, VERA CHARLOTTE; Uceda, J; Mascato, Sv; de la Cal, Jr; Olmedo, Jjs; Martinez, F; Arrendondo, Mt; Cikajlo, I; Peterlin-Potisk, K.
Alpha-synuclein in salivary gland as biomarker for Parkinson's disease 2019 Campo, Flaminia; Carletti, Raffaella; Fusconi, Massimo; Pellicano, Clelia; Pontieri, Francesco E.; Di Gioia, Cira R.; DE VINCENTIIS, Marco
Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease. 2011 Benincasa, Dario; Pellicano, Clelia; Fanciulli, Alessandra; Pontieri, FRANCESCO ERNESTO
Central and peripheral dopamine transporter reduction in Parkinson's disease 2009 Buttarelli, Francesca Romana; Capriotti, Gabriela; Pellicano, Clelia; Daniela, Prosperi; Circella, Annapia; Anna, Festa; Morena, Giovannelli; Anna, Tofani; Pontieri, FRANCESCO ERNESTO; Scopinaro, Francesco
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis 2012 Campbell, Z.; Sahm, D.; Donohue, K.; Jamison, J.; Davis, M.; Pellicano, Clelia; Auh, S.; Ohayon, J.; Frank, J. A.; Richert, N.; Bagnato, F.
Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson's disease from essential tremor 2007 Buttarelli, Francesca Romana; Circella, A; Tiple, D; Giovannelli, M; Benincasa, D; Colosimo, C; Pontieri, FRANCESCO ERNESTO
Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy 2009 Buttarelli, Francesca Romana; Annapia, Circella; Clelia, Pellicano; Dorina, Tiple; Morena, Giovannelli; Carlo, Colosimo; Pontieri, FRANCESCO ERNESTO
Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis 2006 Buttarelli, Francesca Romana; Circella, Annapia; Pellicano, Clelia; Pontieri, FRANCESCO ERNESTO
Entacapone in elderly Parkinsonian patients experiencing levodopa-related wearing-off: a pilot study 2009 Pellicano, Clelia; Benincasa, Dario; Morena, Giovannelli; Buttarelli, Francesca Romana; Ruggieri, Stefano; Pontieri, FRANCESCO ERNESTO
Hemiparkinsonism due to frontal meningioma 2008 Benincasa, Dario; Romano, Andrea; L., Mastronardi; Pellicano, Clelia; Bozzao, Alessandro; Pontieri, FRANCESCO ERNESTO
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease. 2010 Assogna, F; Pontieri, FRANCESCO ERNESTO; Cravello, L; Peppe, A; Pierantozzi, M; Stefani, A; Stanzione, P; Pellicano, Clelia; Caltagirone, C; Spalletta, G.
Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions 2017 Latino, Pamela; Tagliente, Stefania; Pellicano, Clelia; Giovannelli, Morena; Pontieri, Francesco E.
Minocycline in amyotrophic lateral sclerosis: a pilot study 2005 Pontieri, FRANCESCO ERNESTO; Ricci, Alberto; Pellicano, Clelia; Benincasa, Dario; Buttarelli, Francesca Romana
Morphometric changes in the reward system of Parkinson’s disease patients with impulse control disorders 2015 Pellicano, Clelia; Niccolini, Flavia; Wu, Kit; O’Sullivan, Sean S.; Lawrence, Andrew D.; Lees, Andrew J.; Piccini, Paola; Politis, Marios
Neuropharmacology and behavior in planaria: translations to mammals 2008 Buttarelli, Francesca Romana; Pellicano, Clelia; Pontieri, FRANCESCO ERNESTO
Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease 2017 Pellicano, Clelia; Assogna, Francesca; Cellupica, Nystya; Piras, Federica; Pierantozzi, Mariangela; Stefani, Alessandro; Cerroni, Rocco; Mercuri, Bruno; Caltagirone, Carlo; Pontieri, Francesco E.; Spalletta, Gianfranco
Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients 2015 Pellicano, Clelia; Assogna, Francesca; Cravello, Luca; Langella, Roberto; Caltagirone, Carlo; Spalletta, Gianfranco; Pontieri, FRANCESCO ERNESTO
Neuropsychiatric and cognitive symptoms in Parkinson’s disease: the contribution to subtype classification, to differential diagnosis, their clinical and instrumental correlations 2017 Pellicano, Clelia
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 2022 Vacca, Mariacarolina; Assogna, Francesca; Pellicano, Clelia; Chiaravalloti, Agostino; Placidi, Fabio; Izzi, Francesca; Camedda, Riccardo; Schillaci, Orazio; Spalletta, Gianfranco; Lombardo, Caterina; Mercuri, Nicola Biagio; Liguori, Claudio
On the relationship between side of onset and cognition in Parkinson disease: Response from the authors 2015 Pellicano, Clelia; Assogna, Francesca; Cravello, Luca; Langella, Roberto; Caltagirone, Carlo; Spalletta, Gianfranco; Pontieri, FRANCESCO ERNESTO